Our site uses cookies to offer a better navigation functionality, including "third party" cookies and "profiling cookies" designed to send on-line commercial communications in line with the preferences expressed by the user while surfing the internet. Should you wish to receive more information, or deny your consent to some or all cookies, click here to disable them. Upon proceeding with browsing this website, you will be consenting to the use of cookies.
Dexketoprofen+Tramadol

A fixed combination of dexketoprofen and tramadol for the treatment of acute pain of moderate to severe intensity

Current Development: Pre-Registration

Menarini has developed  a fixed combination of dexketoprofen trometamol (NSAID) and tramadol hydrochloride (centrally analgesic agent ) as oral formulation (tablet) for the treatment of acute pain of moderate to severe intensity. Two pivotal studies in post-operative visceral and somatic pain confirmed the clear superior analgesia of the combination above the one achievable by each component alone.

Therapeutic Areas

 

Discover all of Menarini's products marketed in Italy.

READ MORE »

Diagnostics

 

Advanced Technology

READ MORE »

The Menarini Group

 

Discover the leading Italian pharmaceutical company in the world.

READ MORE »

Quality first

 
 

Quality: point of departure and arrival for our drugs.

READ MORE »